Clinical Trial: Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Drug-induced Weight Gain
Study Type: INTERVENTIONAL
Official Title: A Randomized, Open-Label Study of the Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With the Atypical Antipsychotic Drug, Olanzapine
Brief Summary:
This Phase 1b Study RDX-002-22-09 has been planned to evaluate the effect of RDX-002 on postprandial triglycerides and ApoB48 levels in normal healthy subjects treated with the atypical antipsychotic drug, olanzapine.
Read more